glycosylation is the most common protein modification in eukaryotes, affecting over two-thirds of the proteome. Glycosylation is also critical to the pharmacokinetic activity and immunogenicity of many therapeutic proteins currently produced in complex eukaryotic hosts. The discovery of a protein glycosylation pathway in the pathogen Campylobacter jejuni and its subsequent transfer into laboratory strains of Escherichia coli has spurred great interest in glycoprotein production in prokaryotes. However, prokaryotic glycoprotein production has several drawbacks, including insufficient availability of non-native glycan precursors. To address this limitation, we used a constraint-based model of E. coli metabolism in combination with heuristic optimization to design gene knockout strains that overproduced glycan precursors. First, we incorporated reactions associated with C. jejuni glycan assembly into a genomescale model of E. coli metabolism. We then identified gene knockout strains that coupled optimal growth to glycan synthesis. Simulations suggested that these growth-coupled glycan overproducing strains had metabolic imbalances that rerouted flux toward glycan precursor synthesis. We then validated the model-identified knockout strains experimentally by measuring glycan expression using a flow cytometric-based assay involving fluorescent labeling of cell surface-displayed glycans. Overall, this study demonstrates the promising role that metabolic modeling can play in optimizing the performance of a next-generation microbial glycosylation platform.
N -linked glycan, Strain engineering 1. Introduction S1B). All growth-coupled strains contained a knockout of succinate dehy-146 drogenase (sdh) and truncated pentose phosphate pathway (PPP) flux at ei-147 ther glucose 6-phosphate-1-dehydrogenase (zwf ), 6-phosphogluconolactonase 148 (pgl ), or 6-phosphogluconate dehydrogenase (gnd ). 149 Flux analysis of N-glycan production in growth-coupled strains 150 Growth-coupled glycan producing strains had increased glycolytic flux, 151 and decreased amino acid biosynthesis compared to glycan production in the 152 wt strain background (Fig. 3) . We compared the normalized flux values for 153 EcGM2 with the wt strain. Normalizing all fluxes to glucose uptake rate, 154 EcGM2 displayed greater flux through glycolysis by cutting off the PPP via 155 knockout of NADPH-producing gnd (Fig. 3A ). EcGM2 also had decreased 156 synthesis of every amino acid except for glutamine, indicating a source of together, these results suggested the model identified strains that promoted glycan precursor synthesis, primarily UDP-GlcNAc, by creating a combina-184 tion of metabolite and redox imbalance. 185 Experimental validation of N-glycan-producing knockout strains 186 Glycan production was measured in the mutant strains to validate the 187 model predictions (Fig. 4) . Gene knockout strains were constructed using 188 the Keio collection of single gene knockouts E. coli BW25113 [36] as donor 189 strains for P1vir phage transduction. Mutants were constructed containing 190 single, double, and triple knockouts that appeared in growth-coupled strains 191 identified by the constraint-based model. We also performed simulations of 192 each single gene knockout to determine genes that prevented glycan synthe-193 sis; galU, a key enzyme in the synthesis of glycan precursor UDP-glucose, 194 was the only non-lethal knockout that prevented glycan synthesis. out strains were transformed with a plasmid constitutively expressing the 196 C. jejuni pgl locus. To quantify glycan production, we took advantage of were grown in glucose minimal media and harvested during the exponential 208 growth phase, to most closely satisfy the pseudo-steady-state assumption of 209 model predictions.
210
A common feature of the predicted mutant strains was the deletion of 211 pentose phosphate pathway genes zwf/pgl/gnd in combination with ∆sdh.
212
Analysis of the metabolic flux distribution in these mutants suggested the 213 reducing state of the cell as well as the carbon flux was reprogrammed to 214 support enhanced glycan biosynthesis. While hypothetical knockouts such 215 as ∆sdh ∆(zwf/pgl/gnd) ∆pta ∆eutD were predicted to have higher glycan 216 yield, in this study we experimentally evaluated only the simplest growth-217 coupled double knockout family, namely EcGM1. The EcGM1 family had 218 the largest predicted growth rate, was more experimentally tractable than 219 the triple and quad knockouts, and was an unambiguous test of the reduc-220 ing power hypothesis without the complication of the additional deletions. the ∆gnd mutant outperformed the wt strain in glycan synthesis. Over-258 all, our model-guided strategy showed promise toward rationally designing a 259 microbial glycosylation platform. 260 We used simulated annealing and flux balance analysis to search for 261 metabolic and regulatory gene knockouts that produced a growth coupled 262 phenotype. Several constraint-based methods have been developed previ-263 ously to identify gene knockouts that coupled production to growth e.g.,
264
[30, 38, 39]. Most of these methods rely on an OptKnock-like approach, 265 whereby a bi-level mixed integer optimization problem is solved to identify 266 the optimal set of gene knockouts. This class of method guarantees identifica-267 tion of the global optimum; however, it suffers from a few limitations. First, optimum is not guaranteed with these methods, desirable sub-optimal solu-275 tions can be found quickly [38, 40] . Also, heuristic optimization can search 276 efficiently for gene knockouts rather than reaction knockouts. This is an 277 important distinction because the mapping of genes to reactions is not nec-278 essarily one to one. Thus, experimentally, many reactions may be difficult 279 to knock out because they may be catalyzed by the products of many genes. 280 Here, we used simulated annealing in combination with flux balance analysis 281 to maximize the shadow price of growth with respect to glycan flux using a 282 genome scale metabolic reconstruction. The approach identified PPP knock-283 outs that altered the NADH/NADPH balance, and increased glycolytic flux 284 leading to enhanced glycan production. Surprisingly, these knockouts were 285 not in the same section of the metabolism compared with previous litera-286 ture studies. However, this may be expected, as we searched for growth 287 coupled solutions and did not simply increase glycan formation. These so-288 lutions, while more difficult to obtain, offer a significant future advantage; 289 namely, optimization of glycan production could be improved by selecting 290 for increased growth through serial passage.
291
Many aspects of glycoprotein production in E. coli are amenable to in- 
Materials and Methods
Flux balance analysis and heuristic optimization.
Reactions encoding C. jejuni glycan formation (Table 1) were added to the genome-scale metabolic model of E. coli iAF1260 [27]. The combined model was then used to determine growth coupled gene knockouts that improved glycan production flux. Metabolic fluxes were estimated using flux balance analysis. Flux balance analysis requires two assumptions. First, the cell was assumed to operate at a pseudo-steady-state, where the rate of production of every intracellular metabolite was equal to its consumption. Second, the cell has evolved to operate optimally to achieve a cellular objective. Though many objectives have been proposed, we use the most common, namely growth rate (i.e., biomass formation) maximization [45] . The determination of a flux distribution satisfying these assumptions was formulated as a linear optimization problem:
where v is the steady-state flux vector and α i and β i are the lower and up- . Prior to optimization, we removed all genes associated with dead end reactions, since knocking those out would have no effect on the 343 network. Also, we removed duplicate genes, i.e., those that produced iden-344 tical effects when knocked out. Finally, we removed genes whose knockout 345 resulted in zero growth. We searched over both metabolic and regulatory Δv growth
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Figure 2: Heuristic optimization approach used to identify strains coupling growth to glycan production. The chromosome is defined as two separate binary arrays, one defining the state of metabolic enzyme expression and another defining the state of transcriptional regulator activation. Gene repression and knockouts are designated by zeros. Nutrient conditions define the boundary constraints within the stoichiometric model which in turn affect the state of the metabolic enzyme chromosome. Gene repression and knockouts determine the constraints placed on fluxes in the stoichiometric model. Nutrients are mapped to the state of transcriptional regulators and genes are mapped to the state of flux constraints using Boolean rules as defined in [27, 28] . Flux balance analysis is used to maximize growth rate under the constraints imposed by the mutant strain and transcriptional regulation and the fitness objective is calculated. Here, we use shadow price; the strain is accepted or rejected based on the change in fitness and a Boltzmann criterion. New mutant strains are randomly generated from accepted ones. The search continues until a positive shadow price is achieved. Strain Index Figure S1 : Representative simulated annealing simulation results identifying a growthcoupled strain of type EcGM2. (A) Shadow price and FBA-maximized growth rate versus iteration number for the identification of strain ∆sdh∆gnd∆pta∆eutD. (B) Production envelopes of the strains (S1-S3) at the iteration points indicated in A. The simulation was terminated once a positive shadow price is found, visualized by the slope of the production envelope. The red dot indicates the optimal operating point of maximal growth rate for the growth-coupled strain.
